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Approximately 5% of patients with neurofibromatosis type 1 (NF1) exhibit gross deletions that encompass the NF1 gene
and its flanking regions. The breakpoints of the common 1.4-Mb (type 1) deletions are located within low-copy repeats
(NF1-REPs) and cluster within a 3.4-kb hotspot of nonallelic homologous recombination (NAHR). Here, we present the
first comprehensive breakpoint analysis of type 2 deletions, which are a second type of recurring NF1 gene deletion.
Type 2 deletions span 1.2 Mb and are characterized by breakpoints located within the SUZ12 gene and its pseudogene,
which closely flank the NF1-REPs. Breakpoint analysis of 13 independent type 2 deletions did not reveal any obvious
hotspots of NAHR. However, an overrepresentation of polypyrimidine/polypurine tracts and triplex-forming sequences
was noted in the breakpoint regions that could have facilitated NAHR. Intriguingly, all 13 type 2 deletions identified so
far are characterized by somatic mosaicism, which indicates a positional preference for mitotic NAHR within the NF1
gene region. Indeed, whereas interchromosomal meiotic NAHR occurs between the NF1-REPs giving rise to type 1 de-
letions, NAHR during mitosis appears to occur intrachromosomally between the SUZ12 gene and its pseudogene, thereby
generating type 2 deletions. Such a clear distinction between the preferred sites of mitotic versus meiotic NAHR is
unprecedented in any other genomic disorder induced by the local genomic architecture. Additionally, 12 of the 13
mosaic type 2 deletions were found in females. The marked female preponderance among mosaic type 2 deletions contrasts
with the equal sex distribution noted for type 1 and/or atypical NF1 deletions. Although an influence of chromatin
structure was strongly suspected, no sex-specific differences in the methylation pattern exhibited by the SUZ12 gene
were apparent that could explain the higher rate of mitotic recombination in females.
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Deletions in 17q11.2 that encompass the NF1 gene and
its flanking regions constitute the most frequently recur-
ring mutations that cause neurofibromatosis type 1 (NF1
[MIM 162200]). Indeed, ∼5% of all patients with NF1
exhibit deletions of this chromosomal region.1–3 Three sub-
types of these gross NF1 gene deletions have been noted
that differ in terms of deletion size and the positions of
their respective breakpoints: type 1, type 2, and atypical
NF1 deletions. The most common of these are type 1 de-
letions, which encompass 1.4 Mb and lead to the loss of
14 genes, including NF1. Type 1 deletions are mediated
by nonallelic homologous recombination (NAHR) between
low-copy repeats flanking the NF1 gene region, termed
NF1-REPs A and C.4–9 Two preferred regions of NAHR have
been noted within the NF1-REPs: the paralogous recom-
bination sites PRS1 and PRS2.7,9 Of 60 type 1 deletions so
far investigated, 40 have had breakpoints within a 3.4-kb
region spanning PRS2.9 Thus, PRS2 clearly constitutes a
hotspot for NAHR within NF1-REPs A and C. Of the 60
type 1 deletions, 13 have had breakpoints within PRS1, a
1.8-kb region that represents a second preferred site for
NAHR within the NF1-REPs. Importantly, NAHR under-
lying type 1 deletions occurs preferentially during mater-
nal meiosis.10–12 Atypical NF1 deletions are rather less com-
mon than type 1 deletions, and most have nonrecurrent
breakpoints.1,4,11,13–20
Type 2 deletions constitute the second-most-common
type of gross NF1 gene deletion. They span 1.2 Mb and
are characterized by breakpoints within the SUZ12 gene
(GenBank accession number NM_015355) and its pseudo-
gene (SUZ12P [GenBank accession number BC047718]).
SUZ12 is separated from NF1-REP C by 30 kb, whereas an
overlap of 4 kb exists between SUZ12P and NF1-REP A (fig.
1). Type 2 deletions lead to the loss of 13 genes; in contrast
to type 1 deletions, the functional LRRC37B gene within
the distal NF1-REP C is retained in type 2 deletions. A total
of 13 patients with type 2 deletions have been reported
in the literature to date.8,21,22 Since 6 of these 13 patients
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Figure 1. Map of the NF1 gene region indicating the relative sizes and breakpoint positions of type 1 and type 2 NF1 deletions. The
gene loci are indicated as dark bars, and the positions of the NF1-REPs A and C are denoted by gray rectangles. The SUZ12 and SUZ12P
regions are highlighted in black. cen p Centromere; tel p telomere.
Table 1. Clinical Phenotype of Three Newly Reported Female Patients with NF1 and Mosaic Type 2 Deletions
Patient
Age
(years) Clinical Investigation and Phenotype
1104 36 The patient consulted the dermatologist with respect to hyperpigmented macules, present since birth, and papulonodular
lesions on macules and normal skin, which had appeared during her adolescence. Physical examination revealed hyper-
pigmented brownish areas with a chessboard pattern on the skin of the upper back, left shoulder, left arm, left breast,
right shoulder, lumbar region, and right side of the abdomen. Axillary and inguinal freckling was absent. Four to six
soft, skin-colored papulonodular lesions, 1–3 cm in diameter, were noted on the abdomen, thighs, and forearms. The
histopathological investigation of one of these lesions confirmed the clinical diagnosis of a neurofibroma. Results of
ophthalmological examination for Lisch nodules were negative. Abnormalities of her bones were excluded by x-ray anal-
ysis. Neurological and audiological examination also failed to reveal any anomalies. Magnetic resonance imaging (MRI)
of the CNS detected multiple bihemispheric white-substance subcortical lesions, probably of vascular etiology. The angi-
ography MRI results were, however, normal. The patient had never experienced any symptoms of stroke or neurological
disease, nor was there any family history of neurofibromatosis. Her two children, aged 9 and 5 years, exhibited only
light hyperpigmentation on the abdomen, as well as two and one cafe´-au-lait spots, respectively. Results of ophthalmo-
logical examination of the children for Lisch nodules were negative, and neurological examination revealed no
abnormalities.
1502 26 The patient was 168 cm in height and weighed 58 kg. Axillary and inguinal freckling and multiple cafe´-au-lait spots but
!10 subcutaneous neurofibromas were noted. She had attended secondary school but had an IQ of 90. Cerebral and
whole-body MRI scans did not reveal any tumors or other anomalies. Dysmorphic facial features were not noted.
1630 15 The patient had more than six cafe´-au-lait spots and axillary freckling but no confirmed neurofibromas, no large hands and
feet, and none of the other features frequently seen in patients with gross NF1 deletions. The patient was 176 cm in
height, weighed 54 kg, and attended secondary school.
constitute mother-child pairs, they actually represent only
10 independent type 2 deletions. Remarkably, 8 of these
10 patients with type 2 deletions were somatic mosaics.8,21
Because of this somatic mosaicism, patients with type 2
deletions frequently exhibit milder clinical manifestations
of NF1. This might result in an ascertainment bias and
could therefore explain the relatively small number of pa-
tients who have received a diagnosis of type 2 deletions,
as compared with type 1 deletions, which are constitu-
tional and hence are associated with a more severe clinical
phenotype. So far, no somatic (mosaic) type 1 deletions
have been identified unequivocally. The relatively small
number of reported subjects with type 2 deletions might
also be because somatic mosaicism is more difficult to de-
tect, in practical terms.
In addition to a possible ascertainment bias due to the
milder clinical phenotype, the structure, relative target
size, and degree of homology between the two sets of re-
peats (NF1-REPs and SUZ12/SUZ12P) could also be re-
sponsible for the higher frequency of type 1 deletions as
compared with type 2 deletions. The SUZ12 gene and its
pseudogene SUZ12P constitute direct continuous repeats
that display 96.2% sequence identity over a length of 45
kb. By contrast, the NF1-REPs are longer, and their struc-
ture is more complicated, in that they are composed of
homology blocks or subunits separated by nonhomolo-
gous regions.5–7,16,23 NF1-REP A spans 131 kb, whereas NF1-
REP C encompasses 75 kb. The largest homology block
shared by NF1-REP A and NF1-REP C spans 51 kb and
harbors both PRS1 and PRS2. Within this homology block,
the sequence identity is 97.5%,7 slightly higher than the
96.2% identity observed between SUZ12 and SUZ12P.
Until now, the breakpoint regions of only three type 2
deletions have been precisely determined at the DNA se-
quence level.8,21 It has therefore been unclear whether hot-
spots of recombination occur within the SUZ12 sequences
as they do in type 1 deletions, whose breakpoints cluster
tightly within the NF1-REPs.
In this study, we have identified the sites of recombi-
nation underlying the remaining seven uncharacterized
type 2 deletions identified in earlier studies.8,22 Further, we
characterized the breakpoints of three novel, hitherto-un-
reported type 2 deletions. The comparative analysis of the
deletion breakpoint regions has revealed profound differ-
ences between type 1 and type 2 deletions, particularly
with respect to their underlying mutational mechanisms.
Table 2. Mosaicism in the 16 Identified Patients with Type 2 Deletions, as Determined by
FISH and PCR Analysis
Patient Mosaic Sex
Percentage of Cells with Deletion in
Blood Cells
Buccal
Smear Fibroblasts Neurofibroma UrineCultured Uncultured
811 (daughter) No F 100 … … … … …
811-Ma,b (mother) Yes F 93 … … … … …
KCD-3c Yes F 92 … … 51 … …
697c Yes F 97 … 59 … … …
736c Yes F 94 … 59 … … …
1630b Yes F 92 … … … … …
IL39-III2 (son) No M 100 … … … … …
IL39a,d (mother) Yes F 70 … … 15 … …
1104b Yes F 84 94 8 … … 15
SB (daughter) No F 100 … … … … …
WBa,c (mother) Yes F 94 … … … … …
938c Yes F 91 … 80 … … …
1502b Yes F 97 … 70 … … …
488c Yes F 98 … 56 … … …
928c Yes F 100 … 55 … 80 …
HCc,e Yes M 100 … … … … …
NOTE.—FISH was performed with BAC RP11-142O6 (GenBank accession number AC079915), which spans the
proximal portion of the NF1 gene, and BAC RP11-55A13 from 17q24. An ellipsis (…) p not determined.
a The mosaic mother passed the deletion to her offspring.
b Investigated in this study.
c As described elsewhere.8
d As described elsewhere.21
e PCR analysis of polymorphic markers, performed using DNA extracted from buccal smears, indicated that
patient HC also exhibits somatic mosaicism.
Table 3. Methods Employed to Identify the Breakpoint Regions in 13 Patients
with Type 2 Deletions
Patient
Breakpoint Region
Identified
Breakpoint Regions Identified by
PCR Analysis of
Somatic-Cell Hybridsa
Deletion-Junction
PCRb
Array
CGH
811 This study   
KCD-3 Kehrer-Sawatzki et al.8   
697 This study   
736 This study   
1630 This study   
IL39 Petek et al.21   5
1104 This study   
WB Kehrer-Sawatzki et al.8   
938 This study   
1502 This study   
488 This study   
928 This study   
HC This study   
NOTE.—A plus sign () p method identified a breakpoint region; a minus sign () p method
not applied.
a Somatic-cell hybrids containing only the deletion-bearing chromosome 17 were analyzed by
sequence analysis of the PCR products. Evaluation of PSVs that give rise to differences between
the SUZ12 pseudogene and the functional SUZ12 gene potentiated the approximate demarcation
of the region of recombination in each case.
b Primers were designed to allow specific amplification across the breakpoint regions, with the
forward primer located in the SUZ12 pseudogene and the reverse primer in the functional SUZ12
gene. Sequence analysis confirmed that the proximal sequences of the breakpoint-spanning frag-
ments are homologous to SUZ12P (represented by GenBank accession number AC127024), whereas
the sequences at the distal end are homologous to the SUZ12 gene (GenBank accession number
AC090616.12).
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Table 4. Primers Designed to Identify the
Breakpoint Regions of Type 2 NF1
Deletions with Use of Somatic-Cell Hybrid
DNA Containing Only the Deleted
Chromosome 17 as PCR Template
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 6. Primers Designed to Complete
the Cloned 4-kb Breakpoint-Spanning PCR
Fragment Sequence Amplified from
Genomic DNA of Patient 1630
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 5. Primers Designed to Amplify
across the Deletion Breakpoints
(Deletion-Junction PCRs)
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 7. Primers Designed to Complete
the Cloned 5.5-kb Breakpoint-Spanning
Fragment Sequence PCR Amplified from
Genomic DNA of Patient 736
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Material and Methods
Identification of the Type 2 Deletion–Breakpoint Regions
Elsewhere, 13 patients with type 2 deletions were identified by
use of FISH analysis.8,21,22 Here, we report three further patients
in whom type 2 deletions have been identified by FISH (patients
1104, 1630, and 1502). Patients 1630 and 1502 were referred to
the NF1 Clinic in Hamburg, whereas patient 1104 presented at
the Department of Dermatology (Hospital del Mar-Institut Mu-
nicipal d’Assiste`ncia Sanita`ria, Barcelona). DNA was extracted
from patient material after receipt of informed consent. The clin-
ical phenotypes of these three patients are given in table 1. All
16 known patients with type 2 deletions are listed in table 2. Of
these 16 patients, 6 constitute mother-child pairs (three sets). To
identify the breakpoint regions of the 10 as-yet-uncharacterized
type 2 deletions, several different methods were employed (sum-
marized in table 3). In nine cases, the breakpoints were narrowed
down by sequence analysis of PCR fragments amplified from so-
matic-cell hybrids harboring only the deletion-containing chro-
mosome 17. The primer sequences used to refine the respective
deletion breakpoints are listed in table 4. PCR products were se-
quenced by means of an ABI Prism 3100 Genetic Analyzer (Ap-
plied Biosystems). To determine whether the amplified PCR frag-
ments were derived from the SUZ12 gene or the SUZ12 pseudo-
gene, paralogous sequence variants (PSVs) were analyzed as de-
scribed elsewhere.8
To characterize the deletions present in patients 811 and 488,
deletion-junction PCRs were performed using lymphocyte ge-
nomic DNA from the two patients, since no somatic-cell hybrids
were available. These deletion-junction PCRs were designed to
amplify across the deletion breakpoints; the forward primer was
located within SUZ12P, and the reverse primer within the func-
tional gene (primer sequences are listed in table 5). PCRs were
performed using the Expand 20Kb Plus PCR kit (Roche Applied
Science). The respective PCR products were cloned using the
TOPO TA Cloning Kit for Sequencing (Invitrogen) and were com-
pletely sequenced to identify the precise regions of strand ex-
change. Deletion-junction PCRs were also established to confirm
the breakpoint positions of the deletions first determined by the
analysis of somatic-cell hybrids (table 5).
For two deletions (in patients 736 and 1630), the breakpoints
were identified by comparative genomic hybridization (CGH)
with HG18 CHR17 FT arrays (NimbleGen Systems). These oli-
gonucleotide arrays are human chromosome 17–specific arrays,
with a median probe spacing of 160 bp. The SUZ12 gene and its
pseudogene were represented by 153 and 58 oligonucleotide
probes, respectively. Sample labeling, array manufacture, hybrid-
ization, scanning data extraction, and primary data analysis were
performed by NimbleGen as described elsewhere.24 Copy-number
changes were determined by automated segmentation analysis;
this involved the normalization of signal intensities of the test
versus reference, with use of qspline normalization.25 On the basis
of positions of the deletion boundaries and with use of a 4-kb
window size for the mean log2 values of each segment, primers
were designed to amplify across the deletion breakpoints. These
deletion-junction PCRs were performed using primers listed in
table 5. The respective PCR products were cloned and sequenced
from both ends. To complete the sequence of these deletion-
junction (breakpoint-spanning) fragments of 5.5 kb (in patient
736) and 4 kb (in patient 1630), PCRs with primers listed in tables
6 and 7 were performed using cloned fragment DNA as a template.
Sequencing of the respective PCR products then served to identify
the regions of strand exchange during recombination.
Sequence Analysis of the Breakpoint Regions
DNA sequences surrounding 30 deletion-junction sites (230–540
bp in length) flanking the 13 type 2 NF1 deletions (the “case data
set” constituting the known regions of recombination between
the SUZ12 gene and pseudogene) were scanned for the presence
of 37 DNA sequence motifs known to be associated with genomic
instability,26 as well as various “super-hotspot motifs” found in
the vicinity of microdeletions, microinsertions, and indels.27 The
30 analyzed breakpoint-flanking regions were derived from 22
regions flanking the 11 deletions caused by homologous recom-
bination and 8 regions flanking the breakpoints of the 2 deletions
that arose via recombination at nonhomologous sites between
SUZ12 and SUZ12P. In addition, complexity analysis28 was used
to generate decompositions of concatenated flanking sequences,
with respect to direct and inverted repeats, as described else-
where.29 The origins of all fragments 8 bp in length derived
from these decompositions were tracked, and the number and
position of their occurrences in different flanking sequences were
determined. A fragment that was found in six or more sequences,
either as a direct or an inverted copy, was regarded as a potential
recurring sequence motif.
Complexity analysis was also used to search for direct and in-
verted repeats and symmetric elements capable of forming non-
B DNA structures that are known to induce DNA breakage.30 Thus,
the following sequences were sought: direct repeats 8 bp in
length that were !20 bp apart and could form slipped structures;
tetraplexes formed by four GGG, GGGG, or GGGGG repeats and
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Figure 2. Analysis of polymorphic chromosome 17 markers to determine the mechanism underlying the type 2 deletion of patient
697 (A) and to investigate the somatic mosaicism exhibited by patient HC (B). The rectangles highlight markers located within the
region that is deleted on the maternal chromosome in patients 697 and HC.
Table 8. Primers Used to PCR Amplify
Fragments of SUZ12 and SUZ12P, to
Investigate the Methylation Status of CpG
Dinucleotides in Males and Females
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
separated from each other by up to 5 bp; cruciforms formed by
two inverted repeats with the minimum stem size and maximum
loop length set to 8 bp and 20 bp, respectively; triplexes formed
by two symmetric 8-bp elements comprising at least 75% R•Y
bases and separated by up to 20 bp (symmetric elements with at
least 7 bp overlap were also considered to have the potential to
form triplexes); left-handed Z DNA formed by GY•RC repeated at
least six times; and triplet repeat sequences of the form GAA•TTC,
CGG•CCG, and CTG•CAG, with a total length 9 bp, which are
known to induce genetic instability.
To assess the significance of our findings, 100 data sets com-
prising 15 random sequences matching the corresponding orig-
inal breakpoint regions, in terms of their length and nucleo-
tide composition, were simulated by reshuffling the original
sequences. A Z score was calculated31 for each motif and for the
non-B DNA–forming sequences described above. Any Z score in
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Figure 3. Locations of the eight PCR fragments, MSP1–MSI5-1, within the SUZ12 gene. These fragments were analyzed to assess the
methylation status of the SUZ12 gene/pseudogene sequences in males and females. Numbers in bold indicate the positions of the
SUZ12 gene exons. In addition to the designation of the respective PCR fragments, their sizes (in bp) and the numbers of analyzed
CpGs within each fragment are provided. Several fragment-spanning Alu repetitive sequences are also indicated.
Figure 4. Methylation pattern of fragments MSP1–MSI5-1, as
determined in two male and two female control DNA samples. The
legend is available in its entirety in the online edition of The
American Journal of Human Genetics.
the case data set that exceeded the 99th percentile of the maxi-
mum Z score for 100 random data sets was deemed to be statis-
tically significant at the 1% level. Order statistics, R-scans,32 were
used to search for significant clustering of the breakpoint regions
observed along the sequences of the functional SUZ12 gene and
SUZ12P by comparing their distributions with the uniform Pois-
son distribution. Each breakpoint region was represented by its
(1) left boundary, (2) right boundary, or (3) middle position.
Polymorphic-Marker Genotyping
To determine whether the deletion found in patient 697 occurred
by inter- or intrachromosomal recombination and whether pa-
tient HC exhibited somatic mosaicism, analysis of polymorphic
markers on chromosome 17 (fig. 2) was performed by capillary
electrophoresis on an ABI Prism 3100 (Applied Biosystems).
Determination of SUZ12 Gene/Pseudogene Methylation
Status
DNA samples were isolated from the peripheral blood of five
healthy control subjects (two males and three females). Aliquots
(2 mg) of each sample were treated with the Epitect Bisulfite kit
(Qiagen). For the subsequent PCR amplifications, specific primer
sets (listed in table 8) were designed to amplify the sense strand
of the bisulphite-converted SUZ12 genomic DNA. In total, eight
regions of the SUZ12/SUZ12P sequences were analyzed (fig. 3).
These eight fragments contain a total of 109 CpG sites. PCR frag-
ments were amplified from bisulphite-treated DNA from periph-
eral-blood samples of four healthy donors (two males and two
females). For PCR fragments MSI3-1 and MSI5-1, DNA samples
from three female donors were used as a template. To assess the
methylation status of the CpG sites, all PCR fragments were
cloned into the TOPO TA cloning vector (Invitrogen). In total,
310 positive plasmid clones were sequenced using the M13 se-
quencing system, and the methylation status of ∼3,271 CpG sites
was evaluated (fig. 4).
Analysis of SUZ12 and SUZ12P in Chimpanzee
A 15-kb deletion in the genomic sequence of chimpanzee SUZ12P
was identified by BLAT comparison of the human SUZ12 cDNA
and genomic (GenBank accession number AC090616.12) se-
quences with the chimpanzee genome (Ensembl PanTro 2.1). This
deletion was confirmed in both chimpanzee and bonobo by PCR
analysis, with primers located in SUZ12 intron 4 (5′-TTTAGACG-
CTTTCCCCAGAA-3′) and intron 5 (5’-TGATGGATTGAACTCGT-
GGA-3′) of the chimpanzee genomic sequence.
RT-PCR Experiments to Analyze Hypothetical
SUZ12P/SUZ12 Fusion Transcripts
RNA was isolated using the RNeasy Mini-Kit (Qiagen) from (1)
somatic-cell hybrids that contained only the deletion-bearing
chromosome 17 of patients 697, 928, HC, WB, and 1502 and (2)
fibroblast cultures of patient KCD. As a control, RNA was also
isolated from somatic-cell hybrids that contained only the normal
chromosomes of patient 697 and from blood cells of a healthy
male donor. Reverse transcription was performed with the Super-
Script First Strand Synthesis System (Invitrogen). RT-PCR primers
used in the search for hypothetical fusion transcripts are listed
in table 9.
The positions of the primers were chosen according to the anal-
ysis of ESTs derived from SUZ12P, together with the predicted
structure of fusion transcripts (summarized in fig. 5).
Results
In addition to the 13 patients with type 2 deletions re-
ported elsewhere,8,21,22 we identified, by FISH, 3 further
patients with type 2 deletions (patients 1104, 1630, and
1502) (tables 1 and 2). Thus, in total, 16 patients with type
2 deletions have been reported to date. Three of these
patients have constitutional deletions that they inherited
from their mothers, who displayed somatic mosaicism for
these lesions. Thus, with the exclusion of these three in-
herited deletions, 13 independent de novo type 2 dele-
tions have been identified so far, all of whom are somatic
mosaics composed of cells with and without the deletion.
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Table 9. Primers Used for RT-PCR Analysis
of Chimeric Transcripts Generated by
Fusion of SUZ12P with SUZ12 in Patients
with Type 2 Deletions
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 5. Alternative splice variants of the SUZ12 pseudogene. A, SUZ12P exons 1–9, assigned according to BLAST sequence alignments
of the functional SUZ12 gene (GenBank accession number NM_015355 vs. accession number AC127024). Exon 1a is unique to the
SUZ12P and has no homologue in the functional SUZ12 gene. In panel B, the GenBank accession numbers of the SUZ12P ESTs are
indicated on the left of each splice variant. Horizontal bars indicate exons, whereas angled lines represent splicing. The EST with the
GenBank accession number BQ185822 contains an upstream exon 1a encompassing the genomic region 26.060.815–26.060.955 of
chromosome 17 (Ensembl 44, Human Genome Assembly 18 [hg18], National Center for Biotechnology Information [NCBI] build 36). C,
RT-PCR products, detected in patients 697, KCD, 928, and HC, amplified with primers KSFP1f and KSFP1r, and RT-PCR products detected
in patients 1502 and WB, amplified using primers KSFP2f and KSFP1r.
Mosaicism in 8 of these 12 patients has been demonstrated
elsewhere,8,21 whereas 5 patients were investigated for the
first time, with respect to mosaicism, in this study. The
relative proportions of deletion-bearing to wild-type cells
in each patient, as determined by FISH and marker anal-
ysis in different tissues, are summarized in table 2. It ap-
pears that patient HC has a constitutional type 2 deletion,
as determined by the FISH analysis of peripheral-blood
cells.8 In this study, buccal smear DNA from patient HC
was analyzed by PCR genotyping of polymorphic markers,
to demonstrate that this patient was a somatic mosaic (fig.
2).
Identification of the Breakpoint Regions in Type 2 Deletions
The breakpoint region was identified elsewhere in only 3
of the 13 known independent type 2 deletions.8,21 In this
study, we determined the precise locations of the deletion
breakpoints of the remaining 10 type 2 deletions, by var-
ious methods (summarized in table 3). In each case, clon-
ing and sequencing of the deletion junctions revealed the
regions of recombination. There is invariably some am-
biguity with respect to the actual breakpoint sites, because
of the identity between the SUZ12 and SUZ12P sequences
within this region (see the “Sequence Identity in Recom-
bination Regions” section). Despite this, flanking PSVs
clearly indicate that the breakpoints must have occurred
within these regions. Although the deletion breakpoints
were found to occur preferentially within introns 4 and
5 of SUZ12 (table 10), these breakpoints do not cluster in
discrete hotspot regions spanning a few kilobases, as ob-
served for type 1 deletions. Most (11 of 13) of the type 2
deletions nevertheless possess breakpoints that lie with-
in sequences that are homologous between SUZ12 and
SUZ12P, which implies that these events originated as a
consequence of NAHR between SUZ12 and its pseudogene.
However, two deletions (those of patients 928 and HC)
have breakpoints in apparently nonhomologous regions
between SUZ12 and SUZ12P.
Elsewhere, we reported that three type 2 deletions (those
of patients KCD-3, IL39, and WB)8,21 were generated by
intrachromosomal mitotic recombination. In the present
study, SNP genotyping of patient 697 and her family in-
dicated that this type 2 deletion was also mediated by an
intrachromosomal mechanism (fig. 2).
Sequence Identity in Recombination Regions
Of the 13 type 2 deletions, 11 were caused by homologous
recombination between SUZ12 and SUZ12P. In these cases,
the recombination events occurred within regions that are
100% identical between SUZ12 and its pseudogene. Thus,
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Table 10. Properties of the Breakpoint Regions of 13 Type 2 NF1 Deletions
Patient
Breakpoint Recombination
Sequences in
Breakpoint
Region(s)
Intron
Position(s) in
SUZ12P/SUZ12 Regions in SUZ12Pa Regions in SUZ12a Type Mechanismb
811-Mc,d 4 26093151–26093196 27297456–27297501 Homologous ND AluSq
KCD-3d 4 26095311–26095419 27299613–27299721 Homologous Intrachromosomal Unique
697c,d 4 26100313–26100381 27304631–27304699 Homologous Intrachromosomal AluJo
736c,d 4 26104591–26104678 27308894–27308981 Homologous ND AluSx
1630d 4 26108823–26108934 27313160–27313271 Homologous ND Unique
488c,d 5 26111549–26111605 27318189–27318245 Homologous ND AluSg
1502d 5 26111715–26111905 27318355–27318545 Homologous ND AluSc
IL39d 5 26115506–26115552 27322062–27322108 Homologous Intrachromosomal Unique
1104c 5 26115608–26115673 27322160–27322225 Homologous ND Unique
WBd 8 26125231–26125482 27331895–27332146 Homologous Intrachromosomal L1
938c,d 9 26127646–26127756 27334336–27334446 Homologous ND AluSg
928c,d 6 26117984 27327893 Nonhomologous ND Unique
HCc,d 4 and 10 2610411 27339771 Nonhomologouse ND AluSx and AluY
a According to the sequence of chromosome 17 in hg18 (March 2006), NCBI build 36.1, database version 44.36f.
b ND p not determined.
c These breakpoints were identified in this study.
d These patients were reported elsewhere8 to have type 2 deletions. However, the breakpoint regions were identified8,21 for only three of them
(patients KCD-3, IL39, and WB).
e Although the breakpoints occurred in nonhomologous sites in SUZ12P and SUZ12, high sequence similarity between 57-bp segments of Alu
elements was observed at the breakpoints.
the exact breakpoints cannot be precisely defined, and
we refer instead to “regions of recombination” that are
flanked by DNA sequences containing PSVs that can be
used to distinguish between SUZ12 and SUZ12P. These re-
combination regions are 47–253 bp in size (tables 10 and
11). When the sequence identity between SUZ12 and
SUZ12P is determined in windows of 500 bp, including
the recombination region and surrounding sequences, the
sequence identity varies between 93.6% and 97.8%, with
a mean value of 95.9% (table 11). Thus, the sequences sur-
rounding the recombination regions exhibit much lower
levels of homology than do the recombination regions
themselves.
Sequence Analysis of Breakpoint Regions
Two of 37 motifs known to be associated with site-specific
cleavage/recombination, high-frequency mutation, and
gene rearrangement26—namely, short (5-bp) polypurine
and polypyrimidine tracts—were found to be overrepre-
sented at the 1% level within the breakpoint regions of
the type 2 deletions investigated in this study. None of
the so-called super-hotspot motifs found in the vicinity
of microdeletions, microinsertions, and indels, as reported
elsewhere,27 were significantly overrepresented within the
breakpoint regions. However, two novel motifs (T10 and
A10) were found to be overrepresented ( ) in the vi-P ! .01
cinity of the breakpoints. In addition, symmetric T•C–rich
repeats capable of non-B DNA triplex structure formation
were also found to be significantly overrepresented (P !
)..01
NAHR between the SUZ12 gene and its pseudogene ap-
pears to be the mutational mechanism underlying 11 of
the 13 type 2 deletions listed in table 10. Two deletions,
those of patients 928 and HC, manifested breakpoints in
apparently nonhomologous regions of the SUZ12 se-
quences. Thus, for patient HC, the proximal deletion
breakpoint is located within intron 4 of the SUZ12P pseu-
dogene, whereas the distal deletion breakpoint is located
in intron 10 of the functional SUZ12 gene. Short inter-
rupted homologies of !57 bp were evident at each break-
point because of the presence of partial AluSx and AluY
elements (fig. 6). It is therefore likely that the deletion in
patient HC was mediated by homologous recombination
between the Alu repeats.
The breakpoints of the deletion in patient 928 are lo-
cated within different regions of intron 6 of SUZ12P and
SUZ12 (if the SUZ12 and SUZ12P sequences are aligned,
the breakpoints are separated by 3.2 kb). The sequence
similarity at the breakpoints is limited to a hexanucleotide
motif (TTTTGT). We propose that this deletion could have
been mediated by (1) the presence of a short non-B DNA
triplex structure30 whose formation was potentiated by a
TTTTGTCTGTTTT symmetric element in the vicinity of
the second breakpoint, followed by (2) the binding of the
disconnected strand to a hexanucleotide motif in the 3′r5′
strand at the first breakpoint (fig. 6) through the formation
of another non-B DNA triplex structure. This mechanism
indicates how the symmetric T•C–rich repeats found to be
overrepresented in the case data set could have mediated
the reported deletions. Cluster analysis failed, however, to
reveal any clustering of the NAHR breakpoints within the
SUZ12 gene ( ).P ! .05
Analysis of Hypothetical SUZ12P/SUZ12 Fusion Transcripts
The functional full-length SUZ12 protein comprises 739
aa encoded by exons 1–16. NAHR-mediated type 2 dele-
Table 11. Sequence Identity between SUZ12 and SUZ12P in 500-bp Segments, Including
the Recombination Regions of 13 Type 2 NF1 Deletions
Patient
Breakpoint
Length of
Recombination
Regions
(bp)b
Sequence
Identityc
(%)
Intron
Position(s) in
SUZ12/SUZ12P Region in SUZ12Pa Region in SUZ12a
811-M 4 26093151–26093196 27297456–27297501 47 95.1
KCD-3 4 26095311–26095419 27299613–27299721 110 97.4
697 4 26100313–26100381 27304631–27304699 70 95.6
736 4 26104591–26104678 27308894–27308981 89 93.6
1630 4 26108823–26108914 27313160–27313251 93 96.4
488 5 26111549–26111605 27318189–27318245 58 94.0
1502 5 26111715–26111905 27318355–27318545 192 96.7
IL39 5 26115506–26115552 27322062–27322108 48 97.8
1104 5 26115608–26115673 27322160–27322225 67 94.9
WB 8 26125231–26125482 27331895–27332146 253 95.6
938 9 26127646–26127756 27334336–27334446 112 95.6
928 6 26117984 27327893 … 96.8
HC 4 and 10d 26104116 27339771 … 96.4e
a According to the sequence of chromosome 17 in the hg18 (March 2006), NCBI build 36.1, database
version 44.36f.
b In the recombination regions indicated, SUZ12 and SUZ12P exhibit 100% sequence identity.
c In 500-bp windows surrounding and including recombination regions. By way of example, in the case of
the deletion of patient 811-M, we compared the sequence identity between SUZ12 and SUZ12P in a 500-bp–
spanning fragment containing 226 bp proximal to the recombination region, the 47 bp of the recombination
region itself, and 227 bp distal to the recombination region.
d No analogous sequence to SUZ12 exon 10 is present in the SUZ12 pseudogene.
e For intron 4.
Figure 6. Sequence analysis of the deletion breakpoint regions in patients HC (A) and 928 (B). A, Complexity analysis revealed 57-
bp stretches with 87% identity within the breakpoint regions of patient HC in intron 4 of the SUZ12 pseudogene (upper line) and intron
10 (lower line) of the SUZ12 gene. B, Hexanucleotide motif TTTTGT, found at the boundaries of the deletion in patient 928. This motif
forms part of a symmetric element (TTTTGTCTGTTTT) that may have the propensity to form a non-B DNA triplex structure.
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Table 12. Predicted Lengths of Proteins Encoded by Hypothetical SUZ12P/SUZ12 Fusion Transcripts
Assembled in Silico
GenBank Accession numbers
of ESTs Derived from SUZ12P
(Tissue Origin) and ORF
Predicted Lengtha of Putative Proteins in Patients with Type 2 Deletion
811-M, KCD,
697, 736,
and 1630b
488, 1502,
IL39, 6,
and 1104c WBd 928e 938f HCg
BQ185822 (fetal eye):
ORF 1 63h 76i 113i 613i,j,k 113i 31h
ORF 2 63h,l 83h,l 83h,l 83h,l 83h,l 48h,l
ORF 3 634i,l,m 62h,l 62h,l 62h,l 62h,l 384i,l,n
DB451303.1 (testis):
ORF 1 68i 68i 68i 68i 68i 68i
ORF 2 147h,l 147h,l 147h,l 147h,l 147h,l 147h,l
ORF 3 5h,l 5h,l 5h,l 5h,l 5h,l 5h,l
CX761592.1 (blastocyst):
ORF 1 119h,l 119h,l 119h,l 119h,l 119h,l 119h,l
ORF 2 49h,l 49h,l 49h,l 49h,l 49h,l 49h,l
ORF 3 88i 88i 88i 88i 88i 88i
BM562953.1 (adenocarcinoma cell line):
ORF 1 86i 86i 86i 86i 86i 86i
ORF 2 118h,l 118h,l 118h,l 118h,l 118h,l 118h,l
ORF 3 49h,l 49h,l 49h,l 49h,l 49h,l 49h,l
BE166897.1 (head and neck):
ORF 1 6h,l 6h,l 433i,k,o 14h 83h 6h,l
ORF 2 11h,l 573i,k,p 11h,l 11h,l 11h,l 11h,l
ORF 3 9h,l 9h,l 9h,l 9h,l 9h,l 9h,c
NOTE.—Predictions were made in all three possible translation frames and with consideration of the different human EST-
derived splice variants of SUZ12P.
a In amino acids, encoded by the various possible fusion transcripts of SUZ12P and SUZ12.
b Breakpoint located in intron 4.
c Breakpoint located in intron 5.
d In intron 8.
e In intron 6.
f In intron 9.
g In introns 4 and 10.
h The ORF of this transcript does not correspond to the amino acid sequence of SUZ12.
i The ORF of this transcript corresponds to the amino acid sequence of SUZ12.
j The hypothetical protein encoded comprises exons 1a, 5, and 6 of SUZ12P and exons 7–16 of SUZ12.
k The start codon is not in an optimal Kozak79 sequence context.
l This transcript does not include a start codon.
m The hypothetical encoded protein comprises exon 1a of SUZ12P and exons 5–16 of SUZ12.
n The hypothetical encoded protein comprises exon 1a of SUZ12P and exons 11–16 of SUZ12.
o The hypothetical encoded protein comprises exon 5 of SUZ12P and exons 9–16 of SUZ12.
p The hypothetical encoded protein comprises exon 5 of SUZ12P and exons 6–16 of SUZ12.
tions result in the fusion of the genomic sequences of
SUZ12P and SUZ12. The resulting chimeric SUZ12P/SUZ12
genes potentially encode SUZ12-like proteins with altered
N-termini. EST analysis indicates that the SUZ12P gene is
transcribed as shown schematically in figure 5. Taking the
different splice variants of SUZ12P into account, we as-
sembled hypothetical SUZ12P/SUZ12–fusion transcripts in
silico, according to the relative positions of the 13 type 2
deletion breakpoints. Investigation of all three ORFs in-
dicated that the majority of these potential fusion tran-
scripts contain premature stop codons that would be pre-
dicted to encode truncated proteins, with little similarity
to the amino acid sequence of SUZ12 (table 12).
The expression of several chimeric SUZ12P/SUZ12 tran-
scripts was confirmed by RT-PCR analysis of cDNAs de-
rived from primary fibroblasts of patient KCD and from
somatic-cell hybrids containing the deletion-bearingchro-
mosome 17 of patients 697, 928, HC, 1502, and WB (fig.
5). By contrast, SUZ12/SUZ12P–fusion transcripts could not
be amplified from cDNA derived either from somatic-cell
hybrids containing only the normal chromosome 17 of
patient 697 or from blood cells from a healthy donor.
However, none of the SUZ12P/SUZ12–fusion transcripts
detected in patients with type 2 deletions contain an ATG
initiation codon within an optimal sequence context for
translational initiation (namely, a Kozak79 recognition se-
quence). This would appear to render the productive trans-
lation of these putative SUZ12P/SUZ12–fusion transcripts
rather unlikely.
Preponderance of Females among Patients with Type 2
Deletions
Intriguingly, 12 of the 13 type 2 deletions so far identi-
fied have been found in females. To determine whether
this female preponderance was statistically significant, it
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Table 13. Origin of the Sequenced
PCR Fragments
PCR Fragment and
Investigated Individual
No. of Cloned
Fragments
Derived from
SUZ12 SUZ12P
MSI3-1:
Male 1 3 6
Male 2 4 5
Female 1 5 4
Female 2 5 5
MSI4-5:
Male 1 5 1
Male 2 9 1
Female 1 7 0
Female 2 5 1
MSI5-1:
Male 1 10 3
Male 2 9 4
Female 1 11 3
Female 2 10 3
Female 3 8 4
NOTE.—According to the analysis of PSVs
between SUZ12 and SUZ12P.
was necessary to consider the entire cohort of 934 patients
with NF1 referred to the NF1 Clinic at the Department of
Maxillofacial Surgery, University of Hamburg, from which
10 of the 13 type 2 deletion patients were drawn. All these
patients were investigated by analyzing polymorphic
markers located within the NF1 gene region as described
elsewhere,3 and those exhibiting homozygosity/hemizy-
gosity for all markers were further analyzed by FISH. In
total, 43 patients with gross NF1 gene deletions were iden-
tified. Of these, 33 (77%) had type 1 or atypical NF1 de-
letions, whereas 10 (23%) had type 2 deletions. All 10
patients with a type 2 deletion were female, compared
with 19 females and 14 males with type 1 or atypical de-
letions. By comparison with type 1 and atypical deletions,
the female preponderance among patients with type 2
deletions was highly significant ( , by two-tailedPp .001
Fisher’s exact test). Thus, a marked difference in the sex
ratios between type 1 and type 2 deletions is apparent.
Comparative Analysis of Methylation Status at the SUZ12
Locus in Males and Females
The marked predominance of mitotic NAHR between
SUZ12 and SUZ12P in females, compared with males,
could be indicative of a sex-specific difference in chro-
matin conformation in this region of chromosome 17.
Since an inverse relationship has been reported between
DNA methylation and mitotic recombination,33,34 we in-
vestigated whether there might be sex-specific differences
in the degree of DNA methylation of the SUZ12 gene
sequences.
The methylation patterns exhibited by eight SUZ12 re-
gions were examined; four of these regions are located in
the SUZ12 gene promoter (fragments MSP1–4), with four
additional regions located in introns 3, 4, and 5 (fragments
MSI3-1–MSI5-1) (fig. 3). Five of these fragments encom-
pass Alu sequences. PCR fragments were amplified from
bisulphite-treated DNA isolated from peripheral-blood
samples taken from four healthy donors (two males and
two females). In the case of fragments MSI3-1 and MSI5-
1, DNA samples from three female donors were analyzed.
To assess the methylation status of the CpG sites in each
fragment, all PCR fragments were cloned, and at least 10
clones per fragment per individual were sequenced. In to-
tal, 109 CpG sites were investigated in this way (figs. 3
and 4). The analysis of PSVs, which may be used to dis-
criminate between SUZ12 and SUZ12P, indicated that frag-
ments MSP1, MSP2, and MSI4-1 were amplified exclu-
sively from the SUZ12 gene. For fragments MSP3 and
MSP4, no PSVs were present that could have been used
to discriminate between the SUZ12 and SUZ12P se-
quences. Since the sequence identity between SUZ12 and
SUZ12P within these regions is 100%, we may infer that
PCR products MSP3 and MSP4 are probably derived from
both the gene and pseudogene in unknown proportions.
Indeed, PSV analysis of cloned PCR fragments MSI3-1,
MSI4-1, and MSI5-1 indicated that sequences derived from
both SUZ12 and SUZ12P were coamplified to some extent
(table 13). Altogether, the methylation status of a total of
109 CpG sites in 310 different clones was investigated (fig.
4). Modeling CpG site methylation as a function of sex
in a generalized model did not, however, reveal any sig-
nificant difference in the overall degree of cytosine meth-
ylation between females and males ( ).Pp .67
Analysis of SUZ12 and SUZ12 in Chimpanzee
and Macaque
BLAST alignments of exons 1–16 of the functional SUZ12
gene with the sequence of BAC CTD-2349P21 (GenBank
accession number AC127024) spanning the genomic se-
quence of human SUZ12P indicated that the latter is a
nonprocessed pseudogene comprising exons 1–9 of SUZ12
(the SUZ12P pseudogene contains a premature stop codon
in exon 2). Within the coding region of exons 1–9, the
average sequence identity between human SUZ12 and
SUZ12P is 97.8%, with no evident gaps (table 14). Se-
quence alignments of the human SUZ12 gene against the
macaque (Macaca mulatta) genome sequence (MMUL 1.0,
February 2006)35 indicated that only the functional SUZ12
gene is present in the macaque. A comparison of the cod-
ing region of human SUZ12 with its chimpanzee (Pan trog-
lodytes) orthologue revealed 99.9% sequence identity (ta-
ble 15). When the SUZ12P coding sequences were com-
pared between human and chimpanzee, 98% sequence
identity was apparent (table 16). However, the chimpan-
zee SUZ12P pseudogene was found to lack exon 5, as well
as flanking portions of introns 4 and 5. We confirmed this
deletion by PCR analysis and sequencing of an 840-bp
fragment spanning the deletion breakpoints. This ∼15-kb
deletion was also detected by PCR in the bonobo (P. pan-
iscus), the sister species of P. troglodytes, indicating that
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Table 14. Sequence Identity between Human
SUZ12 and SUZ12P
Exon
Length of
(bp)
Sequence
Identity
(%)
Exon in SUZ12P
and SUZ12
Aligned
Sequence
1a 468 468 93.8
2 47 47 97.9
3 65 65 100
4 69 69 100
5 50 50 93.2
6 86 86 100
7 232 232 97.0
8 94 94 97.9
9 106 106 100
NOTE.—The exons of the functional SUZ12 gene included
in the Ensembl transcript ENSG00000178691 were aligned
against the human genome (hg18 [March 2006]), with use
of the BLAT search program at the UCSC Genome Bioin-
formatics Web site.
a Without the 5′ UTR, starting from the ATG codon.
this deletion must have predated the separation of both
chimpanzee lineages 0.86–2 million years ago.36,37
The proximal breakpoint of the deletion observed in
chimpanzee SUZ12P occurs within a unique sequence in
intron 4, whereas the distal breakpoint is located in an
AluSg sequence within SUZ12P intron 5. Residual homol-
ogies were, however, noted in the regions flanking the
proximal and distal breakpoints in the extant human se-
quence (figs. 7A and 7B). In the chimpanzee ancestral se-
quence (after divergence from the human lineage), these
homologies could have been responsible for generating
double-strand breaks through the formation of non-B DNA
slipped structures.30 Although the homology in the vicin-
ity of the proximal breakpoint appears weak, one may
postulate that, over evolutionary time, the human se-
quence acquired mutations that have served to decrease
the homology between the breakpoints to the rather lim-
ited level now evident in this region. Single-stranded DNA
ends flanking the breakpoints were compared as described
elsewhere.38 We postulate that DNA ends B and C could
have formed a hairpin-loop structure mediated by the 21-
bp exact inverted repeats still present in the human se-
quence (fig. 7C). We further speculate that excision of this
hairpin gave rise to the deletion present in the extant
chimpanzee genome. A schematic representation of the
structural elements that could have mediated the deletion
in the chimpanzee is shown in fig. 7D.
When compared with the analogous sequence on hu-
man chromosome 17, this 15-kb region, which is deleted
in chimpanzee SUZ12P, extends from position 26100965
to 26115578. This region also harbors the proximal break-
points of 5 of the 13 type 2 deletions studied here. The
breakpoints of two further type 2 deletions map close to
the deletion boundaries, separated from them by 30 bp
and by 584 bp (fig. 8).
Discussion
NAHR between low-copy repeats constitutes the muta-
tional mechanism underlying a number of different ge-
nomic disorders.39 Gross NF1 deletions also belong to this
group of conditions characterized by local genomic ar-
chitecture that has the propensity to undergo chromo-
somal rearrangement. Although the breakpoints of type 1
NF1 deletions have been extensively characterized,5–7,9
only three breakpoints of type 2 NF1 deletions have been
investigated in any detail.8,21 In this study, we have char-
acterized the breakpoints of 10 type 2 deletions and have
compared the breakpoint positions with those identified
elsewhere.
One of the aims of this study was to investigate whether
the type 2 deletion breakpoints mapped to specific loca-
tions or whether they were widely dispersed within the
SUZ12 gene. By means of cluster analysis, no evidence of
a significant NAHR hotspot for type 2 deletions was found.
Instead, the breakpoint regions of the 13 characterized
type 2 deletions are dispersed over ∼32 kb of the 64-kb–
spanning SUZ12 gene (table 10). Although 6 of the 13 type
2 deletion breakpoints were located within intron 4, the
overrepresentation of breakpoints in intron 4 is not al-
together surprising, because intron 4 is the largest intron
of SUZ12, spanning ∼20.3 kb of the 64-kb SUZ12 gene.
Furthermore, the intron 4 breakpoints were not restricted
to a single location; rather, they spanned a region of ∼16.4
kb. Thus, in contrast to other genomic disorders that are
characterized by spatially very confined NAHR hotspots
(summarized in table 17), no NAHR hotspot was identified
in this study within either the SUZ12 gene or its pseudo-
gene, even though these sequences are homologous along
45 kb of their shared length. This finding clearly serves to
distinguish type 2 NF1 deletions not merely from other
known genomic disorders but also from type 1 NF1 de-
letions. It is, nevertheless, worthy of note that 5 of the 13
type 2 deletions have proximal breakpoints within a re-
gion of the SUZ12 pseudogene encompassing exon 5, the
exon that has been deleted from the chimpanzee genome.
Two other type 2 deletions, those of patients 1104 and
697, have proximal breakpoints that map close to the
boundaries of the chimpanzee-specific SUZ12P deletion,
at distances of 30 bp and 584 bp, respectively (fig. 8). That
this region of SUZ12P is involved both in human mitotic
recombination yielding type 2 NF1 deletions and in me-
diating an evolutionary rearrangement in the chimpanzee
is indicative of its general genetic instability.
Since no NAHR hotspot that could account for the ma-
jority of type 2 deletions appears to be present within the
SUZ12 gene, we sought to ascertain whether certain se-
quence motifs might be present in the breakpoint regions
that could have contributed to double-strand breakage in
these regions. The sequence analysis of the breakpoints
underlying the type 2 deletions investigated here revealed
the significant overrepresentation of short (5-bp) and long
(10-bp) polypurine/polypyrimidine tracts and triplex-
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Table 15. Sequence Identity of the SUZ12 Coding Regions between Human
and Chimpanzee
SUZ12
Exon
Length of
(bp)
Sequence
Identity
(%)
Position on
Chimpanzee
Chromosome 17b
Exon in Chimpanzeea
and Human
Aligned
Sequence
1c 274 274 100 25304630–25304903
2 47 47 100 25301808–25301854
3 65 65 100 25301654–25301718
4 69 69 100 25294073–25294141
5 50 50 100 25275015–25275064
6 86 86 98.9 25267589–25267674
7 232 232 100 25265114–25265345
8 94 94 100 25264212–25264305
9 106 106 100 25257223–25257328
10 178 178 100 25251822–25251999
11 92 92 100 25247009–25247100
12 144 144 100 25246333–25246476
13 158 158 100 25245619–25245776
14 199 199 100 25244579–25244777
15 80 80 100 25243461–25243540
16d 346 346 99 25241342–25241687
a The exons of the human SUZ12 gene included in the Ensembl transcript ENSG00000178691
were aligned against the chimpanzee genome (Ensembl PanTro 2.1 assembly [July 2006]),
with use of the BLAT search program at the UCSC Genome Bioinformatics Web site.
b Numbering is according to the sequence of the chimpanzee genome (Ensembl PanTro 2.1
assembly [July 2006]).
c Without the 5′ UTR, starting from the ATG codon.
d Up to the TGA codon.
forming sequences. These motifs have the propensity to
form non-B DNA structures that are known to be involved
in chromosome breakage, mutation, recombination, and
repair.26,30,46–49 Of the 13 known NF1-associated type 2 de-
letions characterized here, 11 result from homologous re-
combination (table 10). In these cases, the breakpoints
occurred within homologous regions between the SUZ12
gene and its pseudogene. However, two deletions (those
of patients HC and 928) are characterized by breakpoints
that are located in apparently nonhomologous regions of
SUZ12 and SUZ12P. In patient HC, Alu sequences located
in intron 4 of the SUZ12 pseudogene and intron 10 of the
functional SUZ12 gene appear to have been responsible
for mediating the deletion. Alu-Alu recombination has also
been observed in several other deletions associated with
genomic disorders, particularly those with nonrecurring
breakpoints residing within the respective low-copy re-
peats; see, for example, the works of Inoue et al.,50 Shaw
and Lupski,51 and Uddin et al.52 This suggests that, whereas
the nonallelic pairing of genomic regions is facilitated by
higher-order genomic structures such as segmental dupli-
cations, the recombination events themselves may be trig-
gered by shorter repetitive elements such as Alu sequences.51
In patient 928, a hexanucleotide motif (TTTTGT) was noted
at the boundaries of the deletion. This homology is almost
certainly too short for it to have been solely responsible
for mediating this deletion by homologous recombina-
tion; therefore, a nonhomologous mechanism such as non-
homologous end-joining could have been involved. How-
ever, this motif is part of a symmetric element (TTTTGTC-
TGTTTT) that occurs in the vicinity of the deletion break-
points and that may have the potential to form a non-B
DNA triplex structure (fig. 6). This structure could, in turn,
have induced double-strand breaks, thereby initiating the
process of aberrant recombination that led to the deletion
in this patient. Such destabilizing DNA structures have
been identified elsewhere for non-hotspot-related break-
points of deletions in Sotos syndrome.53
NAHR leading to rearrangements in other genomic dis-
orders appears to occur preferentially in 300–500-bp re-
gions of extremely high (199%) sequence identity.6,40–43
Regions of uninterrupted identity within the size range of
134–232 bp have been reported to represent “minimum
efficient processing segments” required for strand ex-
change during somatic recombination in mammalian
cells.54 However, the somatic, non-disease-related NAHR
that is evident between human a-globin genes displays
little requirement for the long, identical homology blocks
shared by these paralogues, since exchanges occur within
intervals as short as 34 bp.55 This is in line with what we
have observed for type 2 NF1 deletions: the recombination
regions characterizing 9 of the 11 deletions that have
arisen by homologous recombination between SUZ12 and
SUZ12P are shorter than 114 bp (table 11).
Detailed analysis of the NAHR hotspot within the
CMT1A repeats has indicated that this hotspot coincides
spatially with a hotspot for allelic homologous recombi-
nation (AHR).56 Intriguingly, a similar situation may be
the case for NF1. Thus, whereas an NAHR hotspot has been
identified at the breakpoints of type 1 NF1 deletions,5–7,9
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Table 16. Sequence Identity of the SUZ12 Pseudogene between
Human and Chimpanzee in Regions Homologous to the Coding Exons
of the Functional SUZ12 Gene
SUZ12P
Exona
Exon Length
(bp)
Aligned
Sequence
Length
(bp)
Sequence
Identity
(%) PositionbChimpanzee Human
1 238 238 238 97.1 26582143–26582478
2 47 47 47 97.9 26579285–26579331
3 65 65 65 100 26579130–26579195
4 69 69 69 100 26571918–26571988
5 Deleted 50 … … …
6 86 86 86 98.9 26563142–26563216
7 231 231 231 98.3 26560657–26560889
8 94 94 94 97.9 26554152–26554262
9 106 106 106 100 26559755–26559857
a SUZ12P exons were assigned according to their homology with the coding exons
of the functional SUZ12 gene extracted from the Ensembl PanTro 2.1 chimpanzee
genome assembly (July 2006).
b According to Ensembl PanTro 2.1, release 44.
comparative analysis of the NF1-REPs on chromosome 17
and a third repeat copy on chromosome 19 has indicated
that REP19 contains an AHR hotspot in the same region
as the NAHR hotspots within the NF1-REPs on chromo-
some 17.9 Taken together, these findings imply that mei-
otic NAHR and AHR are closely related processes that can
display spatial coincidence.
According to the phase I HapMap57 and Perlegen geno-
type data, SUZ12 and SUZ12P represent regions of low
meiotic recombination frequency. This contrasts sharply
with the meiotic recombination hotspot observed in the
closely flanking NF1-REPs A and C. The absence of AHR
hotspots could, therefore, simply be a reflection of the lack
of NAHR hotspots in the SUZ12 sequences. However, the
identification of AHR hotspots might also have been ham-
pered by the lack of high-quality genotyping data from
duplicated sequences.56,57 Thus, resequencing of the SUZ12
gene and its pseudogene in multiple individuals would be
necessary to exclude unequivocally the presence of AHR
hotspots within these regions.
A quite unprecedented finding from this study was that
12 of the 13 mosaic patients with type 2 deletions were
females (table 2). The overrepresentation of females among
patients with type 2 deletion, compared with those with
type 1 and atypical deletions, was found to be statistically
significant. The underlying reason for the apparently
higher rate of mitotic NAHR within the SUZ12 sequences
in females compared with males is, however, unknown.
Significantly higher frequencies of female mitotic recom-
bination at the HLA-A locus, resulting in loss of hetero-
zygosity (LOH) and loss of expression of one of the co-
dominant HLA-A alleles, have been reported elsewhere.58
Further, in the asymptomatic parents of patients with fa-
cioscapulohumeral muscular dystrophy, somaticmosaicism
occurs more frequently in the maternal samples.59 Meiotic
(allelic) recombination events are generally more com-
mon in females than in males.60–63 However, highly local-
ized sex-specific differences in recombination frequency
have been reported in the context of extensive interin-
dividual differences in both meiotic63,64 and mitotic re-
combination frequencies.58 LOH caused by mitotic recom-
bination is a frequent mechanism that leads to somatic
NF1 inactivation and tumorigenesis in patients with
NF1.65,66 However, as yet, neither sex-specific differences
in LOH frequency nor hotspots of recombination have
been identified.
It has been suggested that DNA methylation serves to
suppress mitotic recombination.33,34 Indeed, hypomethy-
lation of the immunoglobulin genes is an important re-
quirement for allele-specific recombination during B-cell
maturation,67,68 whereas the degree of DNA methylation
correlates inversely with the frequency of V(H) gene re-
arrangement.69 Given the possible influence of DNA meth-
ylation on the mitotic recombination rate, we sought
to compare the methylation status of the SUZ12 gene in
healthy males and females. These analyses did not, how-
ever, reveal any obvious sex-specific difference in the
methylation pattern that would account for the inferred
disproportionately higher frequency of mitotic NAHR
leading to type 2 NF1 deletions in females. Other epige-
netic modifications such as histone methylation and
deacetylation could, however, conceivably induce altera-
tions in chromatin structure that might account for the
sex-specific difference in the rate of mitotic NAHR involv-
ing the SUZ12 gene.
SUZ12 is known to be essential for the activity of the
polycomb repressive complex 2, which represses transcrip-
tion through histone H3 methylation70,71 and is required
for specific gene-expression regulation during ES cell dif-
ferentiation.72 Whereas homozygous Suz12 inactivation is
lethal in mouse embryos at early postimplantation stages,
Suz12 heterozygous mice exhibit no obvious differences
in fertility and/or morphology compared with wild-type
mice.73 The consequences of SUZ12 hemizygosity for pa-
Figure 7. A, Extant human DNA sequence surrounding the breakpoints of the deletion detected in chimpanzee SUZ12P. The DNA
sequence shown in bold letters is homologous to that still present in the chimpanzee genome flanking the evolutionary breakpoints,
which are indicated by arrowheads. The human DNA sequence in plain font has been deleted from the chimpanzee genome. With the
assumption that the human sequence is similar to the ancestral sequence, the deletion in the chimpanzee lineage could have been
facilitated by direct repeats (gray) or inverted repeats (underlined). B, Homology evident between the regions flanking the proximal
(a) and the distal (b) breakpoints in the human sequence. The uppercase letters assigned to the DNA ends are given in parentheses.
C, Inverted repeats that could have mediated the deletion. D, Schematic representation of the structural elements that could have
mediated the deletion. Sequences flanking the proximal and distal breakpoints are designated (1) A and B and (2) C and D, respectively.
Breakpoint junctions are marked by a caret (∧). Homologous regions depicted in panel B are denoted by horizontal bars. Inverted
repeats depicted in panel C and their orientations are indicated by horizontal arrows. The DNA sequence deleted as a result of the
resolution of the secondary structure by excision is illustrated by broken lines.
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Figure 8. Scheme of the region encompassing portions of introns 4 and 5 and exon 5 of SUZ12P that is deleted from the chimpanzee
genome (black arrow). The numbers indicate nucleotide positions on human chromosome 17, according to the hg18, NCBI build 36.
Numbers in gray refer to the boundaries of the deletion in chimpanzee. Numbers in black indicate the recombination regions identified
in seven patients with type 2 deletions.
tients with type 1 or type 2 NF1 deletions are, however,
unknown.
It may well be pertinent to note that the SUZ12 (pre-
viously termed “JJAZ1”) gene has been frequently found
to be fused to the JAZF1 gene on chromosome 7 in en-
dometrial stromal tumors by the recurrent translocation
t(7;17).74–77 These somatic translocations lead to the fusion
of two zinc-finger genes; the fusion product is an mRNA
containing 5′-SUZ12 and 3′-JAZF1 sequences. It is currently
unknown whether this fusion inactivates both genes or
whether the fusion leads to a gain of function. Important-
ly, SUZ12 is not the only fusion partner of JAZF1, which
has also been found to be fused to the PHD finger protein
1 (PHF1) gene at chromosome 6p21.78 However, the JAZF1/
PHF1–fusion transcript is expressed under the control of
the PHF1 promoter, in contrast to the JAZF1/SUZ12 fu-
sion.78 Although the molecular and cellular sequelae of
the JAZF1-fusion transcripts remain to be identified, the
recurrence of the tumor-specific t(7;17) involving the
SUZ12 gene provides further evidence of the somatic in-
stability of the SUZ12 gene.
The breakpoint analyses performed in this study have
shown that the SUZ12 gene and its pseudogene constitute
preferred regions for mitotic NAHR in the NF1 gene region
that lead to type 2 deletions. Remarkably, RT-PCR exper-
iments indicated that SUZ12P/SUZ12–fusion mRNAs are
transcribed in patients with type 2 deletions. However,
none of these transcripts contains an AUG translational
initiation codon within an optimal context (as defined by
Kozak79). Further detailed analyses at the protein level are
necessary to assess whether these chimeric transcripts could
be effectively translated into SUZ12-like proteins.
Type 1 and type 2 NF1 deletions appear to differ not
only in terms of their size and breakpoint locations but
also with regard to the underlying mechanism of muta-
genesis. Whereas type 1 deletions are almost exclusively
caused by interchromosomal NAHR during maternal mei-
osis,12 type 2 deletions appear to arise by an intrachro-
mosomal recombinational mechanism during mitosis, as
evidenced by three deletions investigated elsewhere8,21 and
the deletion in patient 697 from this study. Intrachromo-
somal recombination has therefore been observed in a total
of four type 2 deletions investigated to date, whereas in-
terchromosomal recombination has been demonstrated in
the case of six type 1 deletions.12 In a similar vein, whereas
the germline duplication of the CMT1A region is known
to arise almost exclusively via exchanges between homol-
ogous chromosomes,40 somatic deletions involving the du-
plicated a-globin genes in normal human blood cells in-
variably occur by intrachromosomal recombination.55
Taken together, it would appear that there are basic dif-
ferences between somatic and germline NAHR, with sig-
nificant roles played by homologue pairing during meiotic
NAHR and intrachromosomal exchange during mitotic
NAHR.
It has recently been reported that NAHR-mediated in-
versions between duplicated sequences occur at a much
higher frequency in human somatic cells than was pre-
viously suspected.80 These rearrangement-prone duplicate
sequences are quite widespread in the human genome,
although the described inversions appear not to be di-
rectly disease associated. Similarly, deletions mediated by
the duplicated a-globin genes have been found in sperm
cells of healthy human males.55 Thus, duplicated sequences
in the human genome possess considerable potential to
mediate recurring rearrangements in somatic cells, there-
by potentially contributing to genetic disease, particularly
if dosage-sensitive genes are involved, as in the case of the
type 2 NF1 deletions. Remarkably, all 13 known type 2
NF1 deletions investigated here were associated with so-
matic mosaicism and hence must have been mediated by
mitotic NAHR. By contrast, type 1 deletions appear to be
invariably constitutional and mediated by NAHR that oc-
curs mostly during maternal meiosis.12 Thus, a positional
preference for NAHR must exist in the NF1 gene region:
during meiosis, NAHR occurs between the NF1-REPs, giv-
ing rise to type 1 deletions, whereas, during mitosis, NAHR
appears to occur almost exclusively between the SUZ12
gene and its pseudogene, thereby generating type 2 de-
letions. To our knowledge, such a clear distinction be-
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Table 17. Summary of Human Genomic Disorders in Which NAHR Occurs within Hotspots or Preferred Regions of
Recombination
Genomic Disorder Rearrangement
Chromosomal
Region
Repeat
Hotspot/Preferred
Recombination
Region
Block(s) of Shared Homology
Length
(kb) Lengtha
Frequency
of NAHR
(%)
Charcot-Marie-Tooth disease type 1A 1.5-Mb duplication 17p12 CMT1A-REPs 24 557 bp 9040
Hereditary neuropathy with liability
to pressure palsies 1.5-Mb deletion 9141
Azoospermia (male infertility) 780-kb deletion Yq11 HERV15 provirus sequences ∼10 1.3 10042
NF1 1.4-Mb type 1 deletion 17q11.2 NF1-REPs A and C 51 3.4b 679
Sotos syndrome 2-Mb deletions 5q35 Sos-PREP subunit C and Sos-DREP subunit C′ 62.8 and 50.1 2.5 6743
Smith-Magenis syndrome 3.7-Mb deletion 17p11.2 SMS-REPs 170 12 5044
Reciprocal duplication Dup(17)(p11.2p11.2) 12 2344
Williams-Beuren syndrome 1.55-Mb deletion 7q11.23 WBS duplicons, homology block B 105 12 2745
a In kilobases, unless indicated otherwise.
b Termed “PRS2.”
tween the preferred sites of mitotic versus meiotic recom-
bination has not been described in any other human gene
or genomic disorder.
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